Remdesivir cuts COVID-19 death risk by 62%, drugmaker says
Friday, July 10, 2020 - 09:24
in Health & Medicine
The antiviral drug remdesivir has demonstrated that it can lower the risk of death in COVID-19 patients, U.S. drugmaker Gilead Sciences reported in new data Friday.